4//SEC Filing
ATAI Life Sciences AG 4
Accession 0001140361-24-042246
CIK 0001816590other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 8:00 PM ET
Size
6.7 KB
Accession
0001140361-24-042246
Insider Transaction Report
Form 4
ATAI Life Sciences AG
10% Owner
Transactions
- Sale
Ordinary Shares
2024-09-26$6.05/sh−2,660,000$16,093,000→ 6,905,774 total(indirect: By ATAI Life Sciences AG)
ATAI Life Sciences B.V.
10% Owner
Transactions
- Sale
Ordinary Shares
2024-09-26$6.05/sh−2,660,000$16,093,000→ 6,905,774 total(indirect: By ATAI Life Sciences AG)
Footnotes (1)
- [F1]Securities held of record by ATAI Life Sciences AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the Ordinary Shares held of record by ATAI Life Sciences AG.
Documents
Issuer
COMPASS Pathways plc
CIK 0001816590
Entity typeother
IncorporatedGermany
Related Parties
1- filerCIK 0001776242
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 8:00 PM ET
- Size
- 6.7 KB